US 9,321,776 · Application 14/573,887 · Granted Apr 26, 2016
US 9,321,776
Isochromene derivatives as phoshoinositide 3-kinases inhibitors
Estimated expiration
December 17, 2034
8y 56d remaining
Earliest effective filing
Dec 17, 2014
+ 20 years
Dec 17, 2034
PTA +0d
Dec 17, 2034
No TD
—
Final
Dec 17, 2034
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- December 17, 2014
- Earliest effective filing
- December 17, 2014
- Issue date
- April 26, 2016
- PTA
- 0 days
- Base expiry (before PTA)
- December 17, 2034
December 17, 2014 + 20 years = December 17, 2034
Continuity chain
No continuity chain; the patent’s own filing date was used.
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 14/573,887 · US 9,321,776
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,321,776: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9321776Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.